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PSEUDOURIDINE (5-RIBOSYL IJRACIL) EXCRETION IN PSORIASIS*
ARTHUR Z. ETSEN, M.D. AND SHERMAN WEISSMAN, M.D4-
Epidermal hyperplasia represents one of the
characteristic features of psoriasis. Hyperuri-
eemia, and frequently increased urinary excretion
of uric acid, have been noted to be associated
with this hyperplastie process (1) and to be
correlated with the extent of skin involvement
(2). Recent investigation, utilizing glyeine-1-C14
as a precursor of uric acid, has shown that the
abnormal uric acid production in psoriasis may,
in part, be related to a more rapid turnover of
nucleic acids as well as to uric acid formed
directly from nueleotides (2).
Pseudouridine (5-ribosyl uracil), a minor com-
ponent of ribonueleie acid, has recently been
found in human urine (3—5) and to be excreted
in large amounts in patients with gout and leu-
kemia (3, 4, 6). The presence of this compound
in human urine provides a readily measurable end
product of pyrimidine metabolism.
The present study was undertaken to determine
whether an abnormality in pyrimidine metab-
olism, as measured by urinary pseudouridine
levels, is also present in psoriasis. Simultaneous
measurement of uric acid excretion was also
determined in an effort to detect a possible corre-
lation between these two different parameters of
nucleic acid metabolism.
METnOnS
Thirteen adult patients with psoriasis were
studied. All patients were hospitalized throughout
the course of the investigation and were main-
tained on a standard 2600 calorie diet, essentially
free of purines and containing 70 gms. of protein,
350 gms. of carbohydrate and 100 gms. of fat.
Dietary control was essential since previous
studies have demonstrated that variations in
diet contributes to produce changes in the
amounts of both urinary pseudouridine and uric
acid (5, 7).
A period of at least six days was allowed for
equilibration on the diet before urines were col-
lected. Daily twenty-four hour urine collections
were preserved with toluene at room temperature,
and if not used immediately were stored at minus
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10 degrees C. until analyzed. In the majority of
eases analyses were performed in duplicate and
frequently on two successive daily urine collec-
tions. The results of analyses agreed with each
other within ten per cent in almost all instances.
Column chromatographic methods for the
isolation of pseudouridine from one per cent of a
twenty-four hour urine sample have heen de-
scribed in detail elsewhere (5). In brief, the urine
was first passed through Dowex-1 cation and
Dowex-50 anion exchange columns to remove salts
and other interfering substances. Pseudouridine
was separated by column chromatography on
Dowex-1-chloride in a mixed chloride-borate
exponential gradient system. This procedure
gives excellent separation of uracil as well as
pseudouridine (5).
Urinary uric acids were determined by the
method of Praetorius and Poulsen (8) as modified
by Liddle et el. (9). The per cent of skin involved
with psoriasis was estimated by the method of
Evans et al. (10).
RESULTS
The median value for urinary pseudouridine
excretion in a group of 24 normal control sub-
jects maintained on a purine restricted diet was
45 mgms. per day and the average 47 mgms. per
day (6). As a group, the 13 patients with psoriasis
excreted greater than normal amounts of urinary
pseudouridine. The tendency to hyper-exerete
pseudouridine correlated well with the estimated
per cent of skin involved with psoriasis and all
patients with greater than 20 per cent skin
involvement excreted amounts higher than the
normal median (Figure 1). The coefficient of
correlation (r) between these two parameters was
0.78. The patients with greater than 20 per cent
skin involvement had a median urinary pseudo-
uridine level of 64 mgms. per day. One subject,
with the psoriasis in complete remission, ex-
creted only 29 mgms. of pseudouridine daily.
The close association between urinary pseudo-
uridine and urinary urate excretion in these
subjects is of particular interest (Figure 2).
Patients excreting elevated amounts of pseudo-
uridine tended to excrete excessive amounts of
uric acid. The coefficient of correlation (r) for
the association of urinary pseudouridine and
uric acid levels was 0.81. There was no correla-
tion between urinary uric acid and pseudouridine














THE JUtIRNAL OF INVESTIGATIVE DERMATOLOGY
Urinary uracil excretion was determined in
three patients of this group with extensive skin
involvement. The values were elevated in all,
ranging from 10.0 to 13.5 mgms. per day (normal
range of urinary uracil excretion is approximately
4 to 6 mgms. per day).
DISCUSSION
Epidermal hyperplasia and accelerated rate
of cellular reproduction in psoriasis has been
further substantiated and quantitated by the
finding that the "turnover time" of psoriatie
epidermis is 3 to 4 days as compared to approx-
imately 28 days for the epidermis of non-psoriatic
individuals (11).
This increased cellular proliferation must
necessarily be associated with a corresponding
increase in desoxyribonucleic acid synthesis.
Few specific data are available on ribonucleic
acid renewal, but it is likely that there is at
least a proportionate increase in the turnover of
this group of substances. The close correlation
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FIG. 1. Urine pseudouridine values correlated with the estimated per cent of skin involved with
psoriasis. The correlation coefficient, r = 0.78.
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of urinary uric acid and urinary pseudouridine
with per cent of skin involvement suggests that
the amount of these substances excreted in the
urine is a quantitative reflection of the degree of
accelerated epidermal nucleic acid synthesis.
It is not felt that these abnormalities in
nucleic acid metabolism are necessarily a specific
defect associated only with psoriasis, for they
are present in other diseases and might be
expected to be present in all skin diseases as-
sociated with excessive epidermal proliferation.
sUMMARy
1. The amount of pseudouridine excreted in
the urine of patients with psoriasis was found
to be correlated with the per cent of skin in-
volved with the disease.
2. Excretion of pseudouridine by these pa-
tients was found to parallel their urinary excre-
tion of uric acid.
3. The amount of both pseudouridine and
uric acid excreted by patients with psoriasis
probably reflects the degree of accelerated nucleic
acid synthesis in the hyperplastic epidermis of
this disease.
4. Hyper-excretion of these nucleic acid
metabolites does not appear to be a specific
characteristic of psoriasis alone.
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